NR ADOP
AU Dormont,D.
TI How to limit the spread of Creutzfeldt-Jakob disease
QU Infection Control and Hospital Epidemiology 1996 Aug; 17(8): 521-8
KI Infect Control Hosp Epidemiol. 2000 Apr; 21(4): 247-8. PMID: 10782580
PT journal article; review; review, tutorial
AB Transmissible spongiform encephalopathies are rare lethal diseases induced in humans and animals by unconventional agents called transmissible spongiform encephalopathy agents (TSEAs), virions, or prions. Several cases of iatrogenic Creutzfeldt-Jakob disease (CJD) have been reported in the literature after neurosurgery, treatment with pituitary-derived hormones, corneal grafting, and use of dura mater lyophilisates. In a given infected individual, TSEA-associated infectiousness depends on the nature of the organ: the central nervous system has the highest infectiousness, spleen and lymph nodes a medium infectiousness, and organs such as bone, skin, or skeletal muscles do not harbor any detectable infectiousness in experimental models. Transmissible spongiform encephalopathy/prions have unconventional properties; in particular, they resist almost all the chemical and physical processes that inactivate conventional viruses. Therefore, prevention of CJD agent transmission must be taken into account in daily hospital practice. Efficient sterilization procedures should be determined. In tissue and blood donation, donors with a neurologic history must be excluded, and patients treated with pituitary-derived hormones should be considered potentially infected with TSEA and excluded.
ZR 71
MH Animal; *Biological Products; Blood Transfusion; Creutzfeldt-Jakob Syndrome/*prevention & control/transmission; Human; *Infection Control; Prion Diseases/prevention & control/transmission; Prions/*pathogenicity; Sterilization; Transplantation
AD Service de Neurovirologie, CEA/CRSSA/DSV/DRM, France.
SP englisch
PO USA